Boothbay Fund Management’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-69,134	Closed	-$1.55M	–	1589
2024 Q3	$1.55M	Sell	69,134 -47,994	-41%	-$1.08M	0.04%	503
2024 Q2	$2.44M	Buy	117,128 +37,358	+47%	+$780K	0.06%	366
2024 Q1	$1.17M	Buy	+79,770	New	+$1.17M	0.02%	595